Events

The European Mission Soil Week
NOV
Tue
21
NOV
Wed
22
NOV
Thu
23

This was 1 year ago

Location

Spanish National Research Council in Madrid

Programmes
Missions
The European Mission Soil Week is a major European gathering that brings together the European soil community. Researchers, policymakers, farmers, foresters, spatial planners, landowners and land managers, businesses, and organisations as well as the general public will meet to discuss the challenges for making and keeping EU soils healthy.
 
The event will be an opportunity to communicate and disseminate solutions based on the latest research results and innovations for healthy soils. Therefore, the European Mission Soil Week will bring together and mobilise communities to protect and restore soil health.
The European Mission Soil Week will also be livestreamed, allowing everyone to get involved.
 
More information and registration here

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.